iifl-logo

Glenmark Pharmaceuticals Ltd Historical Data

Add as a Preferred Source on Google
2,232.8
(1.50%)
Jul 23, 2026|10:49:59 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Glenmark Pharmaceuticals Ltd Historical Data

23/06/2026calendar-icon
23/07/2026calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

23-Jun-2026

2,191

2,234.92,164.72,179.442,1711,54,82,80,783.63,02,526

24-Jun-2026

2,173.7

2,197.92,1572,180.620,06757,55,00,578.81,07,834

25-Jun-2026

2,180.9

2,1952,147.82,154.430,06075,57,23,446.71,90,816

29-Jun-2026

2,169.9

2,216.32,158.12,186.695,0573,10,14,62,9817,54,346

30-Jun-2026

2,186.7

2,2202,184.52,204.344,8341,83,11,33,019.63,42,139

01-Jul-2026

2,196.4

2,221.22,153.12,161.926,16898,88,44,533.62,27,457

02-Jul-2026

2,174.9

2,214.92,142.82,19633,8521,15,49,22,1982,19,115

03-Jul-2026

2,185.2

2,244.52,185.22,21134,0531,40,20,68,681.22,57,013

06-Jul-2026

2,220

2,2752,216.12,270.934,6541,35,42,05,661.62,77,134

07-Jul-2026

2,278

2,293.92,2432,264.947,0391,75,16,19,333.54,00,738

08-Jul-2026

2,267

2,283.62,212.62,223.723,17575,72,32,1041,23,145

09-Jul-2026

2,227.9

2,293.82,227.12,267.238,50597,11,56,954.71,95,910

10-Jul-2026

2,283.9

2,304.12,2472,282.931,3451,37,53,54,817.53,02,610

13-Jul-2026

2,285.9

2,322.92,2642,301.337,1301,65,59,69,387.52,92,536

14-Jul-2026

2,309

2,326.12,2932,305.125,9491,63,50,28,649.23,69,520

15-Jul-2026

2,316

2,318.92,285.62,297.421,1541,13,14,86,261.82,50,669

16-Jul-2026

2,313

2,3132,280.12,286.914,44136,21,06,25878,765

17-Jul-2026

2,287.9

2,287.92,2292,235.519,64179,98,24,7181,27,559

20-Jul-2026

2,235

2,2702,225.32,239.527,3002,05,07,49,666.95,86,534

21-Jul-2026

2,245.8

2,249.32,221.12,242.115,60161,43,03,550.11,22,180

22-Jul-2026

2,229.8

2,229.82,1662,199.935,8122,07,20,87,800.34,52,804

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.